| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 01/22/2004 | CA2491077A1 Furopyridine and furopyrimidine derivatives for the treatment of hyper-proliferative disorders |
| 01/21/2004 | EP1382597A2 Steroid receptor modulator compounds and methods |
| 01/21/2004 | EP1381615A2 ANTIDEPRESSANT INDOLETETRAHYDROPYRIDINE DERIVATIVES OF 2,3-DIHYDRO-7H- 1,4]DIOXINO 2,3-e]INDOLE |
| 01/21/2004 | EP1381614A2 ANTIDEPRESSANT AZAHETEROCYCLYLMETHYL DERIVATIVES OF 2,3-DIHYDRO-1,4-DIOXINO 2,3-f]QUINOXALINE |
| 01/21/2004 | EP1381612A1 Antidepressant aza-heterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]quinazoline |
| 01/21/2004 | EP1381592A1 1,4-disubstituted benzo-fused compounds |
| 01/21/2004 | CN1469875A Pyrazole compounds useful as protein kinase inhibitors |
| 01/21/2004 | CN1469874A Pyrazole compounds useful as protein kinase inhibitors |
| 01/21/2004 | CN1469748A Pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors |
| 01/20/2004 | US6680326 Antitumor agents; anticancer agents |
| 01/20/2004 | US6680323 Dihydropyrimidines and uses thereof |
| 01/20/2004 | CA2308745C 1'-[4-[1-(4-fluorophenyl)-1h-indole-3-yl]-1-butyl]-spiro[isobenzofuran-1(3h),4'-piperidine]hydrohalogenides |
| 01/15/2004 | WO2004005295A1 Novel tricyclic spiropiperidines or spiropyrrolidines |
| 01/15/2004 | WO2004005289A2 Efficient synthesis of pyropheophorbide a and its derivatives |
| 01/15/2004 | US20040010025 Substituted benzimidazoles, their preparation and their use as agents against parasitic protozoa |
| 01/15/2004 | US20040010019 Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 01/15/2004 | US20040010006 Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-3H-6,9-dioxa-1,3-diazacyclopenta[a]naphthalene |
| 01/15/2004 | US20040009999 Substituted spiroheterocyclic 1H-3-aryl-pyrrolidine-2,4-dione derivatives, processes for their preparation, and their use as pesticides |
| 01/15/2004 | US20040009984 Increasing levels of endogenous growth hormone, especially treating osterporosis, aging frailty or congestive heart failure |
| 01/15/2004 | US20040009978 Bicyclic or tricyclic fused pyrimidine derivatives or salts thereof which possess phosphatidylinositol 3 kinase (PI3K) inhibiting and antitumor activity |
| 01/15/2004 | US20040009977 For use in the prophylaxis and the treatment of Picornavirus and human rotavirus infections. |
| 01/15/2004 | US20040009967 May contain further anticancer or immunosuppressive agents |
| 01/15/2004 | US20040009890 Structure-based design of a drug that can act as an inhibitor of at least two different biological entities using computer modeling; useful for designing HIV protease inhibitors and antineoplastic agents and where drug resistance may exist. |
| 01/15/2004 | CA2492122A1 Novel tricyclic spiropiperidines or spiropyrrolidines |
| 01/14/2004 | EP1380575A1 1,2-disubstituted 1,4-dihydro-4-oxoquinoline compounds |
| 01/14/2004 | EP1380573A2 Isoquinolines and preparation thereof |
| 01/14/2004 | EP1380306A1 Remedies for psychoneurosis |
| 01/14/2004 | EP1379523A1 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists |
| 01/14/2004 | EP1379498A1 Sulphones which modulate the action of gamma secretase |
| 01/14/2004 | EP1272491B1 Perylene-derivative based crystallization modifiers |
| 01/14/2004 | EP1019385B1 Aminoaryl oxazolidinone n-oxides |
| 01/14/2004 | CN1468243A Polymorphs of an epothilone analog |
| 01/14/2004 | CN1468227A Non-imidazole aryloxyalkylamines |
| 01/14/2004 | CN1468217A Aliphatic nitrogenous five-membered ring compounds |
| 01/14/2004 | CN1468216A Nitrogenous five-membered ring compounds |
| 01/14/2004 | CN1468211A Nitroso diphenylamine derivatives |
| 01/14/2004 | CN1467210A 20-esterifiable camptothecine derivative and method for making same and pharmaceutical combination and uses |
| 01/14/2004 | CN1467209A 4,6-dihydrofuran [3,4-d] imidazole-6- ketone derivative and salt and preparation method thereof |
| 01/14/2004 | CN1134436C Pharmaceutically available protoberberine salt derivatives, and protoberberine derivatives and salt thereof |
| 01/13/2004 | US6677382 Halogenated oxyamines, used as enzyme inhibitors for prophylaxis of atherosclerosis and cardiovascular disorders, and as antilipemic agents |
| 01/13/2004 | US6677380 Antilipemic agents such as 3(3-(4-chloro-3-ethyl-phenoxy)-phenyl)((3-(1,1,2,2 -tetrafluoroethoxy)phenyl)methyl))amino)-1,1,1-trifluro-2-propanthiol, used for prophlaxis of cardiovascular disorders and atherosclerosis |
| 01/13/2004 | US6677379 Such as 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl) amino)-1,1,1-trifluoro-2-propanol for treatment of coronary artery disease |
| 01/13/2004 | US6677375 Substituted N,N-bis-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 01/13/2004 | US6677356 Concurrently administering pyridoxal-5'-phosphate, pyridoxamine, pyridoxal, or a 3-acylated pyridoxal analogue with angiotensin converting enzyme inhibitor,calcium channel blocker, adrenergic blocking agent, vasodilator or diuretic |
| 01/13/2004 | US6677353 Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 01/13/2004 | US6677332 Amide-substituted piperidine or azepine derivatives to treat drug abuse and tinnitus |
| 01/13/2004 | US6677110 Dye-forming coupler, silver halide photographic light-sensitive material, and azomethine dye compound |
| 01/13/2004 | US6676909 Method for recovery of metals from metal-containing materials using medium temperature pressure leaching |
| 01/13/2004 | CA2053359C Heteroaroyl derivatives of monocyclic beta-lactam antibiotics |
| 01/08/2004 | WO2004002992A1 Compounds |
| 01/08/2004 | WO2004002986A2 Novel benzimidazole derivatives |
| 01/08/2004 | WO2004002960A1 Substituted quinoline ccr5 receptor antagonists |
| 01/08/2004 | WO2004002959A1 Novel azasugar derivative and drug containing the same as the active ingredient |
| 01/08/2004 | WO2004002948A1 Amide compound and medicinal use thereof |
| 01/08/2004 | WO2004002490A2 Piperidine compounds as antibacterials |
| 01/08/2004 | WO2004002406A2 Bicyclic pyrimidinones as coagulation cascade inhibitors |
| 01/08/2004 | WO2003084928A8 Alpha, omega-dicarboximide derivatives as useful uro-selective α1α adrenoceptor blockers |
| 01/08/2004 | WO2002080164A9 Optical recording medium |
| 01/08/2004 | US20040006121 Total synthesis of merrilactone A |
| 01/08/2004 | US20040006096 Substituted alkanohydroxamic acids and method of reducing TNFalpha levels |
| 01/08/2004 | US20040006079 Substituted 2,4-dihydro-pyrrolo[3,4-b]quinolin-9-one derivatives useful as phosphodiesterase inhibitors |
| 01/08/2004 | US20040006065 Bicyclic pyrimidinones as coagulation cascade inhibitors |
| 01/08/2004 | US20040006063 Dipeptide derivatives |
| 01/08/2004 | DE10226943A1 Phenylaminopyrimidine und ihre Verwendung Phenylaminopyrimidine and their use |
| 01/08/2004 | CA2494249A1 Novel azasugar derivative and drug containing the same as the active ingredient |
| 01/08/2004 | CA2489560A1 Substituted quinoline ccr5 receptor antagonists |
| 01/07/2004 | EP1378512A1 Optically pure camptothecin analogues |
| 01/07/2004 | EP1378505A1 Method of synthesizing camptothecin-relating compounds |
| 01/07/2004 | EP1377978A2 Optical data carrier whose information layer contains a light-absorbing compound having a number of chromophoric centers |
| 01/07/2004 | EP1377976A2 Optical data carrier that contains a merocyanine dye as the light-absorbing compound in the information layer |
| 01/07/2004 | EP1377975A2 Optical data medium containing, in the information layer, a dye as a lightabsorbing compound and having a protective covering layer of predetermined thickness |
| 01/07/2004 | EP1377974A1 Optical data carrier containing a xanthene dye in the information layer thereof as a light-absorbing compound |
| 01/07/2004 | EP1377973A1 Optical data memories containing an axially substituted co-phthalocyanine in the information layer that can be written with light |
| 01/07/2004 | EP1377971A1 Optical data carrier that contains a cationic aminoheterocyclic dye as the light-absorbing compound in the information layer |
| 01/07/2004 | EP1377970A1 Optical data carrier containing a cyclizable compound in the information layer |
| 01/07/2004 | EP1377968A2 Optical data carrier that contains a heterocyclic azo dye as the light-absorbing compound in the information layer |
| 01/07/2004 | EP1377587A1 Protein phosphate inhibitors |
| 01/07/2004 | EP1377577A1 Pyrrole derivates for treating cytokine mediated diseases |
| 01/07/2004 | EP1377555A1 Novel compounds |
| 01/07/2004 | EP1377549A1 Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor |
| 01/07/2004 | EP0958285B1 TRICYCLIC BENZO[e]ISOINDOLES AND BENZO[h]ISOQUINOLINES |
| 01/07/2004 | CN1466577A 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient |
| 01/07/2004 | CN1466456A Sgk2 and Sgk3 used as diagnostic and therapeutic targets |
| 01/07/2004 | CN1465577A Camptothecin derviative and preparation process thereof |
| 01/07/2004 | CN1133634C Heterocyclic derivatives which inhibit factor Xa |
| 01/06/2004 | US6673930 Preparing a selective glucocorticoid receptor agents by cyclization, dehalogenation, amination, etherification, hydroxylation |
| 01/06/2004 | US6673814 Controlled-release by implantable devices, delivery pumps, wafers, and biodegradable polymers |
| 01/06/2004 | US6673781 Inhibit secretory phospholipase a2-mediated fatty acid release; treating adult respiratory syndrome, pancreatitis, bronchial asthma, allergic rhinitis, chronic rheumatism, arteriosclerosis, cerebral infarction and psoriasis |
| 01/02/2004 | EP1375503A1 Dioxino derivatives and their use as dopanine agonists |
| 01/02/2004 | EP1375496A1 N-aryl-substituted cyclic amine derivative and medicine containing the same as active ingredient |
| 01/02/2004 | EP1375486A1 Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity |
| 01/02/2004 | EP1374234A1 Optical data support comprising a hemicyanin dye in the information layer as light-absorbing compound |
| 01/02/2004 | EP1374233A1 Optical data carrier that contains a triazacyanine dye as the light-absorbing compound in the information layer g |
| 01/02/2004 | EP1373275A2 Highly purified and crystalline form of harringtonine |
| 01/02/2004 | EP1373259A1 Pyridazinone aldose reductase inhibitors |
| 01/02/2004 | EP1373219A1 Thiohydantoins and use thereof for treating diabetes |
| 01/02/2004 | EP1373214A1 Rylene derivatives and their use as dyes |
| 01/02/2004 | EP1373199A2 Spiro-cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteinases and tnf-alpha converting enzyme (tage) |
| 01/02/2004 | EP1372653A2 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 01/01/2004 | US20040002604 Phenylalkynes |